Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Potential HSV-2 vaccine described by Aviron

May 5, 1997

Novel immunosuppressants from Takeda

April 29, 1997

BioChem Pharma's novel flu vaccine meets phase I trial endpoints

April 28, 1997

MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies

April 28, 1997

Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein

April 28, 1997

WF-10917: new immunosuppressant from Fujisawa

April 24, 1997

North American Vaccine's acellular pertussis vaccine approved in Sweden

April 23, 1997

Connaught prepares Bordetella vaccine

April 22, 1997

Ergo Science and Massachusetts General Hospital conclude licensing agreement

April 18, 1997

MEDI-507 heads for clinical trials

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...